Chemical ecology: a view from the pharmaceutical industry

Area of Science:

• Biochemistry
• Drug Discovery
• Molecular Evolution

Background:

• Biological diversity stems from molecular diversity, offering natural solutions to evolutionary challenges.
• Understanding these natural molecules accelerates the discovery and design of new human disease treatments.
• Nature provides drug discovery leads through natural products, genetic variations, and organisms manipulating biochemical pathways.

Purpose of the Study:

• To explore how molecular diversity in nature aids drug discovery and medicinal chemistry.
• To highlight the role of natural products and biochemical pathways in identifying drug targets and leads.
• To discuss strategies for optimizing drug leads derived from natural sources.

Main Methods:

• Screening diverse natural product extracts (microorganisms, plants, insects) using high-throughput assays.
• Designing screens to identify compounds affecting specific human receptors, enzymes, ion channels, or biochemical pathways.
• Utilizing knowledge of target biochemistry and structural homology to guide lead identification and optimization.

Main Results:

• Natural products, while rarely drugs themselves, serve as valuable leads for medicinal chemistry.
• Knowledge of target biochemistry and conserved protein structures aids in designing effective drug leads.
• Optimizing lead specificity involves targeting variation to specificity-determining sites.

Conclusions:

• Nature's molecular solutions are crucial for advancing drug discovery and treatment development.
• Medicinal chemistry efforts are significantly enhanced by leveraging natural product diversity and biochemical insights.
• Strategic structural modification of natural leads increases the efficiency of creating novel therapeutic molecules.